WebApr 11, 2024 · 2 Wall Street research analysts have issued 12-month price targets for Palatin Technologies' stock. Their PTN share price forecasts range from $50.00 to $70.00. On average, they anticipate the company's stock price to reach $60.00 in the next twelve months. This suggests a possible upside of 2,081.8% from the stock's current price. WebThe analyst consensus target price for shares in Palatin Technologies is $43.00. That is 1534.98% above the last closing price of $2.63. Analysts covering Palatin Technologies currently have a consensus Earnings Per Share (EPS) forecast of …
Palatin Technologies Pipeline
WebSep 29, 2024 · Its mission is to connect entrepreneurs, investors, companies, and physicians to advance ophthalmic innovation through live conferences, virtual programming, and a … WebFeb 15, 2024 · CRANBURY, N.J., Feb. 15, 2024 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the ... francia jazz előadók
Palatin Technologies (@PalatinTech) / Twitter
WebJun 10, 2014 · CRANBURY, N.J., June 10, 2014 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, announced today that the U ... WebJun 6, 2024 · According to Global Data, the heart failure market across US, France, Germany, Italy, Spain, the UK, and Japan is expected to grow from $3.7 billion in 2016 to around … Web"We are pleased to have patent protection on our next generation of new peptides with improved profiles that target the melanocortin-4 receptor," stated Carl Spana, Ph.D., President and CEO of Palatin. A Notice of Allowance is issued after the USPTO makes a determination that a patent can be granted from an application. francia jazz énekesnő